Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel IAP inhibitors patented by Aegera Therapeutics

Sep. 13, 2011

Oncothyreon starts enrollment in phase II PX-866 trial

Sep. 13, 2011

Genprex provides update on nanomolecular cancer therapy

Sep. 13, 2011

Final data disclosed from randomized menatetrenone trial in hepatocellular carcinoma

Sep. 13, 2011

New tumor-homing peptide improves effects of IL-12 gene therapy in vivo

Sep. 13, 2011

Silence Therapeutics and InteRNA Technologies enter miRNA agreement

Sep. 12, 2011

Taiho sets date for Japanese launch of Zolinza

Sep. 12, 2011

Peregrine Pharmaceuticals completes enrollment in phase II bavituximab trial

Sep. 12, 2011

Ongoing ALTTO study modified

Sep. 12, 2011

Genentech discloses new brain-penetrant PI3K inhibitors

Sep. 12, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...